Related Experiment Video
Updated: Sep 1, 2025

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Structural and biochemical analyses of Bcl-xL in complex with the BH3 domain of peroxisomal testis-specific 1
Dahwan Lim1, Sein Jin2, Ho-Chul Shin3
1Critical Diseases Diagnostics Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea; Department of Biochemistry, Chungnam National University, Daejeon, 34134, South Korea.
Abstract:
Antiapoptotic B-cell lymphoma-2 (Bcl-2) proteins suppress apoptosis by interacting with proapoptotic regulators. They commonly contain a hydrophobic groove where the Bcl-2 homology 3 (BH3) domain of Bcl-2 family members or BH3 domain-containing non-Bcl-2 family proteins can be accommodated. Peroxisomal testis-specific 1 (Pxt1) was previously identified as a male germ cell-specific protein whose overexpression causes germ cell apoptosis and infertility in male mice. Sequence and biochemical analyses also showed that human Pxt1, which is composed of 134 amino acids and is longer than mouse Pxt1 consisting of only 51 amino acids, has a BH3 domain that interacts with antiapoptotic Bcl-2 proteins, including Bcl-2 and Bcl-xL. In this study, we determined the crystal structure of Bcl-xL bound to the human Pxt1 BH3 domain. The five BH3 consensus residues are well conserved in the human Pxt1 BH3 domain and make a critical contribution to the complex formation in a canonical manner. Structural and biochemical analyses also demonstrated that Bcl-xL interacts with the BH3 domain of human Pxt1 but not with that of mouse Pxt1, and that residues 76-83 of human Pxt1, absent in mouse Pxt1, play a pivotal role in the intermolecular binding to Bcl-xL. While Bcl-xL consistently colocalized with human Pxt1 in mitochondria, it did not do so with mouse Pxt1, when expressed in HeLa cells. Collectively, these data verified that human and mouse Pxt1 differ in their binding ability to the antiapoptotic regulator Bcl-xL, which might affect their functionality in controlling apoptosis.
Insights
Human and mouse Pxt1 proteins differ in their ability to bind Bcl-xL, an antiapoptotic regulator. This structural difference in the Pxt1 BH3 domain affects protein interactions and may influence apoptosis regulation.
Area of Science:
- Molecular Biology
- Structural Biology
- Cell Biology
Background:
- Antiapoptotic B-cell lymphoma-2 (Bcl-2) proteins regulate apoptosis by interacting with proapoptotic factors.
- These proteins feature a hydrophobic groove for accommodating BH3 domains.
- Peroxisomal testis-specific 1 (Pxt1) is a male germ cell protein implicated in germ cell apoptosis and infertility.
Purpose of the Study:
- To determine the crystal structure of Bcl-xL bound to the human Pxt1 BH3 domain.
- To investigate the differential binding of human and mouse Pxt1 to Bcl-xL.
- To elucidate the role of specific Pxt1 residues in Bcl-xL interaction.
Main Methods:
- X-ray crystallography to determine protein complex structure.
- Biochemical assays to assess protein-protein interactions.
- Cellular expression studies (HeLa cells) to analyze protein colocalization.
Main Results:
- The crystal structure revealed canonical binding of the human Pxt1 BH3 domain to Bcl-xL.
- Bcl-xL specifically interacts with human Pxt1 but not mouse Pxt1.
- Residues 76-83 in human Pxt1 are crucial for Bcl-xL binding and are absent in mouse Pxt1.
- Human Pxt1, but not mouse Pxt1, colocalized with Bcl-xL in mitochondria.
Conclusions:
- Human and mouse Pxt1 exhibit distinct binding capabilities to the antiapoptotic regulator Bcl-xL.
- Differences in the Pxt1 BH3 domain, particularly residues 76-83, mediate specific interactions with Bcl-xL.
- These binding differences suggest varying functional roles of human and mouse Pxt1 in apoptosis regulation.
More Related Videos
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
09:30Analyzing Dynamic Protein Complexes Assembled On and Released From Biolayer Interferometry Biosensor Using Mass Spectrometry and Electron Microscopy
Published on: August 6, 2018